Alexander KarpAlexander Karp earned $1B in 2024

In 2023, Gustavo J. Pesquin earned $950.00K in total compensation at Amneal Pharmaceuticals, Inc., including $500.00K salary, $100.00K bonus and $300.00K in stock. 3+ years at the helm of Amneal Pharmaceuticals, Inc..

Compensation History

Annual executive compensation data for Gustavo J. Pesquin, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$950.00K

Salary

$500.00K

Bonus

$100.00K

Other

$50.00K

Salary

$500.00K

Board Justification

The compensation philosophy aligns with company performance and aims to retain top talent through competitive pay structures.

Bonus

$100.00K

Board Justification

The bonus is based on the company's performance metrics including revenue growth and EBITDA targets for the fiscal year 2023.

Other Compensation

$50.00K

Board Justification

Other compensation includes health benefits and retirement contributions.

Restricted Stock

$300.00K20K RSU

Board Justification

The vested stock consists of RSUs that were granted in previous years and vested in 2023.

Performance Metrics

Performance metrics include revenue growth, EBITDA targets, and overall company performance relative to peers.

A

Gustavo J. Pesquin

CEO of Amneal Pharmaceuticals, Inc.

Education

M.B.A. from Kellogg GSM, Northwestern University and a B.A. from Universidad Nacional de Cuyo in Argentina.

Sector of Economy

Healthcare

Born

January 1, 1970 - 55 years ago

CEO of Amneal Pharmaceuticals, Inc. for

3 years 3 months (Sep 2022 - Present)

Previous Experience

North America Head for General Medicines at Sanofi US.

Holdings

Track Gustavo J. Pesquin's stock holdings and portfolio value over time.

Insider Trading

Gustavo J. Pesquin's recent stock transactions, purchases, and sales filed with the SEC.

No insider trades found for this CEO.

Rivals

Compare Gustavo J. Pesquin with competitor CEOs and industry peers.